Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2020

01-10-2020 | Original Research

Daily Short Message Service Reminders Increase Treatment Compliance and Efficacy in Outpatients with Functional Dyspepsia: a Prospective Randomized Controlled Trial

Authors: Bo Wang, PhD, Qing-Qing Luo, PhD, Qing Li, B.S., Li Cheng, B.S., Sheng-Liang Chen, MD

Published in: Journal of General Internal Medicine | Issue 10/2020

Login to get access

Abstract

Background

Many outpatients with functional dyspepsia (FD) do not follow the medication schedule recommendations, which can lead to illness relapse.

Objective

To investigate whether short message service (SMS) reminders improve medication regimen adherence and therapeutic efficacy in outpatients with FD.

Design

Participants with FD were randomly allocated to the control group or intervention group. Patients in the control group received a 4-week medication treatment with no reminders, those in the intervention group received medication treatment plus a daily SMS reminder of dose and medication time.

Participants

Newly diagnosed FD patients from April 2019 to June 2019 were recruited from the GI outpatient clinics at Renji Hospital.

Measurements

The scores for FD symptoms (LDQ) and psychological conditions (PHQ-9 for depression and GAD-7 for anxiety) were assessed before and after the treatment. The medication possession ratio (MPR) was calculated.

Key Results

A total of 352 eligible patients was enrolled in the study. The overall compliance rates of patients in the intervention and control groups were 87.5% and 80.7% in the intention-to-treat (ITT) analysis (P = 0.08) and 94.48% and 86.59% in per-protocol (PP) analysis (P = 0.015), respectively. In the intervention group, the compliance rate of younger patients (age ≤ 40 years) was significantly higher than that of age-matched patients in the control group (ITT: 86.1% vs. 70.5%, P = 0.018). Compared with the control group, the reduction in scores of LDQ (9.33 vs. 8.02, P = 0.017), PHQ-9 (6.97 vs. 5.69, P = 0.004), and GAD-7 (8.70 vs.7.53, P = 0.028) was significantly greater in patients receiving SMS reminders. The MPR of patients positively correlated with the reduction in scores of LDQ, PHQ-9, and GAD-7 in both groups.

Conclusions

SMS reminders can improve treatment compliance and efficacy in patients with FD.

Trial Registration

NCT04052750
Appendix
Available only for authorised users
Literature
1.
go back to reference Enck P, Azpiroz F, Boeckxstaens G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081.CrossRef Enck P, Azpiroz F, Boeckxstaens G, et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081.CrossRef
2.
go back to reference Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150:1380-92.CrossRef Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150:1380-92.CrossRef
3.
go back to reference Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049-57.CrossRef Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049-57.CrossRef
4.
go back to reference Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:120-30.CrossRef Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:120-30.CrossRef
5.
go back to reference Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:329-39.CrossRef Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22:329-39.CrossRef
6.
go back to reference Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142:1510-8.CrossRef Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012;142:1510-8.CrossRef
7.
go back to reference Moayyedi PM, Lacy BE, Andrews CN, et al. Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112:1484.CrossRef Moayyedi PM, Lacy BE, Andrews CN, et al. Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112:1484.CrossRef
8.
go back to reference Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.CrossRef Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.CrossRef
9.
go back to reference Moayyedi P, Delaney BC, Vakil N, et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127:1329-37.CrossRef Moayyedi P, Delaney BC, Vakil N, et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127:1329-37.CrossRef
10.
go back to reference Cassell B, Gyawali CP, Kushnir VM, et al. Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients. Am J Gastroenterol. 2015;110:1382-7.CrossRef Cassell B, Gyawali CP, Kushnir VM, et al. Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients. Am J Gastroenterol. 2015;110:1382-7.CrossRef
11.
go back to reference Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12.CrossRef Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12.CrossRef
12.
go back to reference Reid MJ, Dhar SI, Cary M, et al. Opinions and attitudes of participants in a randomized controlled trial examining the efficacy of SMS reminders to enhance antiretroviral adherence: a cross-sectional survey. J Acquir Immune Defic Syndr. 2014;65:e86-8.CrossRef Reid MJ, Dhar SI, Cary M, et al. Opinions and attitudes of participants in a randomized controlled trial examining the efficacy of SMS reminders to enhance antiretroviral adherence: a cross-sectional survey. J Acquir Immune Defic Syndr. 2014;65:e86-8.CrossRef
13.
go back to reference Thakkar J, Kurup R, Laba TL, et al. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA Intern Med. 2016;176:340-9.CrossRef Thakkar J, Kurup R, Laba TL, et al. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA Intern Med. 2016;176:340-9.CrossRef
14.
go back to reference Vervloet M, Linn AJ, van Weert JC, et al. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19:696-704.CrossRef Vervloet M, Linn AJ, van Weert JC, et al. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19:696-704.CrossRef
15.
go back to reference Castaldelli-Maia JM, Scomparini LB, Andrade AG, et al. Perceptions of and attitudes toward antidepressants: stigma attached to their use--a review. J Nerv Ment Dis. 2011;199:866-71.CrossRef Castaldelli-Maia JM, Scomparini LB, Andrade AG, et al. Perceptions of and attitudes toward antidepressants: stigma attached to their use--a review. J Nerv Ment Dis. 2011;199:866-71.CrossRef
16.
go back to reference Lee YJ, Kim ES, Choi JH, et al. Impact of reinforced education by telephone and short message service on the quality of bowel preparation: a randomized controlled study. Endoscopy. 2015;47:1018-27.CrossRef Lee YJ, Kim ES, Choi JH, et al. Impact of reinforced education by telephone and short message service on the quality of bowel preparation: a randomized controlled study. Endoscopy. 2015;47:1018-27.CrossRef
17.
go back to reference Krol N, Muris JW, Schattenberg G, et al. Use of prescribed and non-prescribed medication for dyspepsia. Scand J Prim Health Care. 2004;22:163-7.CrossRef Krol N, Muris JW, Schattenberg G, et al. Use of prescribed and non-prescribed medication for dyspepsia. Scand J Prim Health Care. 2004;22:163-7.CrossRef
18.
go back to reference Van Soest EM, Siersema PD, Dieleman JP, et al. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther. 2006;24:377-85.CrossRef Van Soest EM, Siersema PD, Dieleman JP, et al. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther. 2006;24:377-85.CrossRef
19.
go back to reference Zhou R, Wu C, Rau P-LP, et al. Young driving learners’ intention to use a handheld or hands-free mobile phone when driving. Transport Res F: Traffic Psychol Behav. 2009;12:208-217.CrossRef Zhou R, Wu C, Rau P-LP, et al. Young driving learners’ intention to use a handheld or hands-free mobile phone when driving. Transport Res F: Traffic Psychol Behav. 2009;12:208-217.CrossRef
20.
go back to reference Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137:94-100.CrossRef Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137:94-100.CrossRef
21.
go back to reference Tan VP, Cheung TK, Wong WM, et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol. 2012;18:6127-33.CrossRef Tan VP, Cheung TK, Wong WM, et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol. 2012;18:6127-33.CrossRef
22.
go back to reference Jackson JL, O’Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000;108:65-72.CrossRef Jackson JL, O’Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000;108:65-72.CrossRef
23.
go back to reference Ford AC, Luthra P, Tack J, et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66:411-420.CrossRef Ford AC, Luthra P, Tack J, et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66:411-420.CrossRef
24.
go back to reference Fortney JC, Pyne JM, Edlund MJ, et al. Reasons for antidepressant nonadherence among veterans treated in primary care clinics. J Clin Psychiatry. 2011;72:827-34.CrossRef Fortney JC, Pyne JM, Edlund MJ, et al. Reasons for antidepressant nonadherence among veterans treated in primary care clinics. J Clin Psychiatry. 2011;72:827-34.CrossRef
25.
go back to reference Zhong BL, Chen HH, Zhang JF, et al. Prevalence, correlates and recognition of depression among inpatients of general hospitals in Wuhan, China. Gen Hosp Psychiatry. 2010;32:268-75.CrossRef Zhong BL, Chen HH, Zhang JF, et al. Prevalence, correlates and recognition of depression among inpatients of general hospitals in Wuhan, China. Gen Hosp Psychiatry. 2010;32:268-75.CrossRef
26.
go back to reference Sirey JA, Bruce ML, Alexopoulos GS, et al. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52:1615-20.CrossRef Sirey JA, Bruce ML, Alexopoulos GS, et al. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52:1615-20.CrossRef
27.
go back to reference Sirey JA, Banerjee S, Marino P, et al. Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017;74:1129-1135.CrossRef Sirey JA, Banerjee S, Marino P, et al. Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017;74:1129-1135.CrossRef
Metadata
Title
Daily Short Message Service Reminders Increase Treatment Compliance and Efficacy in Outpatients with Functional Dyspepsia: a Prospective Randomized Controlled Trial
Authors
Bo Wang, PhD
Qing-Qing Luo, PhD
Qing Li, B.S.
Li Cheng, B.S.
Sheng-Liang Chen, MD
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 10/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06088-3

Other articles of this Issue 10/2020

Journal of General Internal Medicine 10/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.